Patents by Inventor Michael V. W. Bergamini

Michael V. W. Bergamini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • R-reliprodil for treating glaucoma
    Publication number: 20030212107
    Abstract: Methods for treating glaucoma with R-eliprodil alone and in combination with other agents for treating glaucoma are disclosed.
    Type: Application
    Filed: October 28, 2002
    Publication date: November 13, 2003
    Inventors: Michael A. Kapin, Michael V.W. Bergamini, Verney L. Sallee
  • Prostaglandin analogues for promotion of hair growth
    Publication number: 20030199590
    Abstract: Methods and compositions for the promotion of hair growth in mammals, comprising PGF2&agr; analogues are disclosed.
    Type: Application
    Filed: November 6, 2002
    Publication date: October 23, 2003
    Inventors: Gerald D Cagle, Michael V.W. Bergamini
  • Diclofenac and tobramycin formulations for ophthalmic and otic topicaluse
    Patent number: 5597560
    Abstract: This invention includes a pharmaceutically acceptable formulation of Diclofenac, Tobramycin, a solubility agent and, optionally, excipients, tonicifiers, buffers, viscosity modifying agents, preservatives, and chelating agents, at a pH from greater than 7.0 to about 9. The invention also discloses the use of this pharmaceutically acceptable formulation of an antibiotic and NSAIDs to treat eye and ear conditions accompanied by infection and inflammation.
    Type: Grant
    Filed: April 10, 1995
    Date of Patent: January 28, 1997
    Assignee: Laboratorios Cusi, S.A.
    Inventors: Michael V. W. Bergamini, Jose A. Vallet Mas, Gemma T. Cabello, Antonio L. Cabrera
  • Entrapment of water-insoluble compound in alpha tocopherol-based vesicles
    Patent number: 5330689
    Abstract: Methods and compositions are described for the preparation of alpha-tocopherol vesicles, the bilayers of which comprise a salt form of an organic acid derivative of alpha-tocopherol such as the Tris salt form of alpha-tocopherol hemisuccinate. The method is rapid and efficient and does not require the use of organic solvents. The alpha-tocopherol vesicles may be used to entrap compounds which are insoluble in aqueous solutions. Such preparations are especially useful for entrapping bioactive agents of limited solubility, thus enabling administration in vivo.
    Type: Grant
    Filed: March 29, 1993
    Date of Patent: July 19, 1994
    Assignee: The Liposome Company, Inc.
    Inventors: Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini, Robert L. Suddith
  • Method for preparing alpha-tocopherol vesicles
    Patent number: 5234634
    Abstract: Methods and compositions are described for the preparation of alpha-tocopherol vesicles, the bilayers of which comprise a salt form of an organic acid derivative of alpha-tocopherol such as the Tris salt form of alpha-tocopherol hemisuccinate. The method is rapid and efficient and does not require the use of organic solvents. The alpha-tocopherol vesicles may be used to entrap compounds which are insoluble in aqueous solutions. Such preparations are especially useful for entrapping bioactive agents of limited solubility, thus enabling administration in vivo.
    Type: Grant
    Filed: October 17, 1990
    Date of Patent: August 10, 1993
    Assignee: The Liposome Company, Inc.
    Inventors: Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini
  • Alpha tocopherol-based vesicles
    Patent number: 5041278
    Abstract: Methods and compositions are described for the preparation of alpha-tocopherol vesicles, the bilayers of which comprise a salt form of an organic acid derivative of alpha-tocopherol such as the Tris salt form of alpha-tocopherol hemisuccinate. The method is rapid and efficient and does not require the use of organic solvents. The alpha-tocopherol vesicles may be used to entrap compounds which are insoluble in aqueous solutions. Such preparations are especially useful for entrapping bioactive agents of limited solubility, thus enabling administration in vivo.
    Type: Grant
    Filed: December 6, 1988
    Date of Patent: August 20, 1991
    Assignee: The Liposome Company, Inc.
    Inventors: Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini
  • Composition using salt form of organic acid derivative of alpha-tocopheral
    Patent number: 4861580
    Abstract: Methods and compositions are described for the preparation of alpha-tocopherol vesicles, the bilayers of which comprise a salt form of an organic acid derivative of alpha-tocopherol such as the Tris salt form of alpha-tocopherol hemisuccinate. The method is rapid and efficient and does not require the use of organic solvents. The alpha-tocopherol vesicles may be used to entrap compounds which are insoluble in aqueous solutions. Such preparations are especially useful for entrapping bioactive agents of limited solubility, thus enabling administration in vivo.
    Type: Grant
    Filed: September 24, 1986
    Date of Patent: August 29, 1989
    Assignee: The Liposome Company, Inc.
    Inventors: Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini, Robert L. Suddith
  • Method of treating vascularization of the eye with Flurbiprofen
    Patent number: 4230724
    Abstract: A method of treating vascularization of the eye as a result of traumatic injury, surgery, such as, corneal transplant, or onset of diabetic retinopathy by topically treating the eye with Flurbiprofen or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 16, 1979
    Date of Patent: October 28, 1980
    Assignee: Allergan Pharmaceuticals, Inc.
    Inventors: Charles A. Cooper, Michael V. W. Bergamini